1. Home
  2. REAX vs TYRA Comparison

REAX vs TYRA Comparison

Compare REAX & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • REAX
  • TYRA
  • Stock Information
  • Founded
  • REAX 2018
  • TYRA 2018
  • Country
  • REAX United States
  • TYRA United States
  • Employees
  • REAX N/A
  • TYRA N/A
  • Industry
  • REAX
  • TYRA Biotechnology: Pharmaceutical Preparations
  • Sector
  • REAX
  • TYRA Health Care
  • Exchange
  • REAX Nasdaq
  • TYRA Nasdaq
  • Market Cap
  • REAX 820.5M
  • TYRA 681.7M
  • IPO Year
  • REAX N/A
  • TYRA 2021
  • Fundamental
  • Price
  • REAX $3.44
  • TYRA $15.36
  • Analyst Decision
  • REAX Strong Buy
  • TYRA Strong Buy
  • Analyst Count
  • REAX 3
  • TYRA 7
  • Target Price
  • REAX $6.33
  • TYRA $30.71
  • AVG Volume (30 Days)
  • REAX 1.5M
  • TYRA 237.0K
  • Earning Date
  • REAX 10-30-2025
  • TYRA 11-14-2025
  • Dividend Yield
  • REAX N/A
  • TYRA N/A
  • EPS Growth
  • REAX N/A
  • TYRA N/A
  • EPS
  • REAX N/A
  • TYRA N/A
  • Revenue
  • REAX $1,617,846,000.00
  • TYRA N/A
  • Revenue This Year
  • REAX $52.77
  • TYRA N/A
  • Revenue Next Year
  • REAX $19.10
  • TYRA N/A
  • P/E Ratio
  • REAX N/A
  • TYRA N/A
  • Revenue Growth
  • REAX 72.57
  • TYRA N/A
  • 52 Week Low
  • REAX $3.57
  • TYRA $6.42
  • 52 Week High
  • REAX $6.61
  • TYRA $20.50
  • Technical
  • Relative Strength Index (RSI)
  • REAX 28.34
  • TYRA 63.11
  • Support Level
  • REAX $3.86
  • TYRA $13.75
  • Resistance Level
  • REAX $3.96
  • TYRA $15.54
  • Average True Range (ATR)
  • REAX 0.17
  • TYRA 0.79
  • MACD
  • REAX -0.02
  • TYRA 0.01
  • Stochastic Oscillator
  • REAX 0.00
  • TYRA 88.43

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are TYRA-300, TYRA-200, and TYRA-430: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: